Presenting author

Yeismel Miranda Valdes

1 presentation

PS04-4201. ML-007C-MA, a novel investigational M1/M4 muscarinic agonist in Phase 2 development for the treatment of schizophrenia and Alzheimer’s disease psychosis
2026 ECNP Congress